• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Gates Foundation

Gates Foundation

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Tadataka Yamada, Ph.D., Former Head of GlaxoSmithKline and Takeda R&D, Re-Joins Frazier Healthcare

    Tadataka Yamada, Ph.D., Former Head of GlaxoSmithKline and Takeda R&D, Re-Joins Frazier Healthcare

  2. Sika Boosted in Battle to Fend Off Saint-Gobain Takeover Bid--Update

    Sika Boosted in Battle to Fend Off Saint-Gobain Takeover Bid--Update

  3. Sika Boosted in Battle to Fend Off Saint-Gobain Takeover Bid

    Sika Boosted in Battle to Fend Off Saint-Gobain Takeover Bid

  4. New Jersey's Hart and Celgene and Johnson & Johnson Executives Named to Scientific American Worldview 100 Most Influential People in Biotechnology

    New Jersey's Hart and Celgene and Johnson & Johnson Executives Named to Scientific American Worldview 100 Most Influential People in Biotechnology

  5. Saudi Prince Pledges $32 Billion to Good Causes With Women's Rights a Focus

    Saudi Prince Pledges $32 Billion to Good Causes With Women's Rights a Focus

  6. Synlogic to Present at Several Upcoming Scientific and Industry Conferences

    Synlogic to Present at Several Upcoming Scientific and Industry Conferences

  7. Mark Zuckerberg, Wife Donate $5 Million to TheDream.US

    Mark Zuckerberg, Wife Donate $5 Million to TheDream.US

  8. Buffett's Succession Plan Should Have Little Downside

    Although the public is still uncertain who will succeed the Oracle, the split-up of the chairman, CEO, and investment roles likely won't alter Berkshire's overall strategy.

  9. Paying It Forward

    Opinions and statements of financial market trends that are based on current market conditions constitute our judgment and are subject to change without notice. We believe the information provided here is reliable but should not be assumed to be accurate or complete. The views and strategies ...

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.